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Background: The orthopoxvirus strain Modified Vaccinia virus Ankara (MVA) rapidly induces innate immune
responses. Previously, we demonstrated that CCL2 and CCR1 are important players in MVA induced recruitment of
leukocytes to the lung. Alveolar macrophages are sentinel cells in the lung, which are likely amongst the first cells
of the immune system to encounter and respond to virus during respiratory infection. Therefore we examined the
potential of the murine alveolar macrophage MH-S cell line as a model to study chemokine expression during
infection with MVA and vaccinia virus (VACV) strain Western Reserve (WR).
Findings: MVA but not VACV infected MH-S cells increased the expression of the CXCR2 acting chemokine CXCL2.
MH-S cells constitutively produced CCL2 and CCR1 acting chemokines CCL3, CCL5 and CCL9. Consequently,
supernatants of mock treated and virus infected MH-S cells induced chemotaxis of murine promyelocyte MPRO cells
and human monocytic THP-1 cells at the same level. However, supernatants of MVA infected MH-S cells significantly
increased chemotaxis of the CCR2 deficient human monocytic cell line U-937. Chemotaxis of all three cell types was
inhibited by J 113863, a CCR1 antagonist. Additionally, we show that MVA but not VACV WR infection of THP-1 cells
induces expression of C-C motif and C-X-C motif chemokines and generates a chemotactic activity for monocytes,
which was J 113863 sensitive.
Conclusions: These results extend our previous findings, demonstrating that MVA but not VACV WR induces
chemokine production in alveolar macrophages and monocytes, which can induce recruitment of monocytes in a
CCR1 dependent manner.
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Highly attenuated, replication deficient vaccinia strains
such as Modified Vaccinia virus Ankara (MVA) are in-
creasingly used as viral vectors for the development of
new vaccines. Intranasal inoculation is an attractive
route of vaccination for delivery of MVA to mucosal tis-
sue in the respiratory tract, which was found to be both
safe and immunogenic in a phase I clinical trial [1]. A
distinguishing feature of MVA is its ability to activate
a robust innate immune response [2-4]. We recently
showed that MVA triggers the production of chemo-
kines in primary lung fibroblasts and bone marrow* Correspondence: Michael.Lehmann@lmu.de
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unless otherwise stated.derived macrophages (BMDM) which induce chemotaxis
of neutrophils [5].
Alveolar macrophages (AM) are permanent residents
of the lung which are capable of exerting both pro- and
anti-inflammatory immune responses. Due to their pre-
sence on the luminal surface of the respiratory system
AM are likely amongst the first cells to encounter virus
after respiratory infection. Indeed, it has been shown
that AM help to control VACV infection, and their de-
pletion exacerbates the host inflammatory response to
viral infection, which is probably due to the increased
viral burden [6]. However little is known about the early
immune responses that is elicited in AM upon encounter
with VACV or highly attenuated strains such as MVA. Ac-
tivation of AM is tightly regulated by the local microenvir-
onment, cell-cell interactions and soluble mediators thatral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and removal of these signals leads to spontaneous activa-
tion of AM [7]. Consequently, our attempts to investigate
cytokine expression in AM ex-vivo were largely unsuc-
cessful due primarily to strong cytokine production in
non-infected cells and rapid cell death of infected cells
after isolation by bronchoalveolar lavage (data not shown).
Therefore we tested the immortalized murine alveolar
macrophage MH-S cell line [8] as a model system for
MVA induced chemokine expression.
To determine whether MH-S cells are permissive to
vaccinia virus infection and gene expression, cells were
infected with MVA expressing the green fluorescent pro-
tein (GFP) under control of the P7.5 early/late promoter
[9], and analysed using a MACSQuant VYB flow cyto-
meter (Miltenyi Biotec). This showed that MH-S cells
are readily infected with MVA and are permissive to
viral gene expression (Figure 1A). Analysis by RT-PCR
and ELISA showed that the CXCR2 ligand CXCL2 wasFigure 1 Murine alveolar macrophage MH-S cells produce neutrophil
MVA. A) MH-S cells were infected with MVA-GFP at the indicated MOI and
were infected with MVA or VACV WR at an MOI of 0.5 and 1, or challenged
subsequently by specific RT-PCR as indicated. Fold induction of CXCL2 and
Image Lab 5.0 (Bio-Rad). Data from mock-treated cells were set to 1. C) Cell cu
were harvested 8 h p.i. and D) 16 h p.i., and chemokine concentrations determ
least two independent experiments, *, P < 0.05; ANOVA with Bonferroni post-induced by MVA but not by VACV WR in MH-S cells
confirming our previous finding in primary murine lung
fibroblasts [5]. Increased mRNA and protein levels of
CXCL2 were detected at 8 h p.i., and the amount of CXCL2
produced depended on the MOI applied (Figure 1B, C
and D). CXCL1 was only induced by LPS in MH-S cells,
whereas CXCL5/6 (GCP-2/LIX), another neutrophils
attracting chemokine [10], was not. Functionality of the
GCP-2 specific PCR was demonstrated using RNA from
murine alveolar epithelial MLE-12 cells treated with LPS
or with supernatant from LPS challenged MH-S cells
(Additional file 1).
Recently, we showed that CCR1 plays an important
role in the recruitment of CD11b+Ly6Chi inflammatory
monocytes into the lung [5]. Monocytes express the che-
mokine receptor CCR2 [11], and CCL2, a ligand for this
receptor, has been shown to be important for MVA
induced monocyte migration in vitro and in vivo [12].
However, monocytes are a heterogeneous population,-attracting chemokines constitutively and after infection with
infectivity was measured 16 h p.i. by flow cytometry. B) MH-S cells
with LPS (1 μg/ml). Total RNA was isolated 8 h p.i. and investigated
CCL2 were calculated based on the intensity of PCR products using
lture supernatants of MVA and VACV WR infected MH-S cells (1 MOI)
ined by specific ELISA. Data are means ± SD and are representative of at
hoc test.
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CCR1 expression is up-regulated on differentiating mono-
cytes, leading to increased sensitivity to CCR1 ligands
whilst simultaneously decreasing sensitivity to CCR2 li-
gands [14]. Consequently, we asked whether CCR1 also
plays a role in mediating MVA triggered monocyte
chemotaxis.
Unfortunately, the CCR1 ligands CCL3, CCL5 and
CCL9, as well as the CCR2 ligand CCL2, were constitu-
tively expressed in MH-S cells, and the levels were not
increased by MVA or VACV WR infection (Figure 1B
and C). Consequently, chemotaxis of murine promyelo-
cyte MPRO cells was increased by supernatants from
mock and virus infected MH-S cells to a similar level
and decreased when MPRO cells were pre-incubated
with the CCR1 antagonist J 113863 (Figure 2). Superna-
tants from LPS challenged MH-S cells induced less
chemotaxis as compared to supernatants from mock in-
fected cells. A possible explanation is that LPS-induced
interleukin-10 in MH-S cells may have decreased the
constitutive protein production of the C-C motif chemo-
kines in a negative autocrine feedback loop [15,16].
To avoid the masking effect of CCL2 when investigat-
ing MVA for its potential to induce a CCR1 dependent
chemotactic activity in cells of the monocyte/macro-
phage lineage we took advantage of the human mono-
cytic cell line U-937, which, under our cell culture
conditions, did not express CCR2 in contrast to human
monocytic THP-1 cells (Figure 3A and B) [17]. Firstly,Figure 2 Supernatants from MH-S cells increase chemotaxis of
murine promyelocyte MPRO cells in a CCR1 dependent manner.
MPRO cells were tested for chemotaxis towards control medium
(CM), human CCL3 (20 ng/ml) and supernatants from MH-S cells
(16 h) challenged with LPS (1 μg/ml) or infected with MVA or VACV
WR at an MOI as indicated using a 96-well Multi-Screen-MIC plate
with a 5 μm pore-sized filter (Millipore). 75.000 cells were placed in
the upper part and cells migrated into the lower part were counted
after 3 h. Where indicated MPRO cells were pre-incubated with 20
nM of the CCR1 antagonist J 113863 for 5 min prior to running the
assay. Data are means ± SD (n = 3).
Figure 3 Supernatants from MVA but not VACV WR infected
MH-S cells increase chemotaxis of U-937 cells in a CCR1
dependent manner. A) Total RNA from THP-1 cells (T) and U-937
cells (U) were isolated and used for GAPDH, CCR1 and CCR2 transcript
variant A specific RT-PCR. B) Total RNA was isolated from cells as
indicated and a multiprobe ribonuclease protection assay using
hCR-8 (BD Biosciences) as probe was performed as previously
described [12]. C) Verification of J 113863 to block CCR1 specific
chemotaxis of THP-1 cells. Human CCL3 at concentrations as indicated
was added to the lower part of a 96-well Multi-Screen-MIC plate with
an 8 μm pore-sized filter (Millipore). 75.000 cells were placed in the
upper part and cells migrated into the lower part were counted after
90 min. Data are means ± SD (n = 3). D) Human monocytic THP-1 cells
(left panel) and U-937 cells (right panel) were tested for chemotaxis
towards control medium (CM) and supernatants from mock, MVA
or VACV WR infected MH-S cells (1 MOI, 16 h) as described in C).
Where indicated, cells were pre-incubated with 5 nM of the CCR1
antagonist J 113863 for 5 min prior to running the assay. THP-1 cells
and U-937 cells were allowed to migrate for 90 min and 30 min,
respectively. Data are means ± SD (n = 3 for THP-1 cells; n = 6 for
U-937 cells) and are representative of at least two independent
experiments, **, P < 0.01; ANOVA with Bonferroni post-hoc test.
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also capable of inducing chemotaxis of THP-1 cells. This
was possible since human chemokine receptors CCR1
and CCR2 can also be activated by the relevant murine
ligands [18-20]. As with MPRO cells, supernatants from
mock and virus infected MH-S cells increased chemo-
taxis of THP-1 at a similar level, which was decreased
when THP-1 cells were pre-incubated with J 113863
(Figure 3D, left panel). Supernatants from MVA infected
MH-S cells increased the chemotaxis of U-937 cells
compared to supernatants from mock infected and
VACV WR infected MH-S cells. Importantly, this
chemotaxis of U-937 cells was significantly reduced
when U-937 cells were pre-incubated with J 113863
(Figure 3D, right panel). Of note, J 113863 also acts on hu-
man CCR3 but this receptor was not expressed in either
cell line (Figure 3B). Interestingly, despite the constitutive
expression of CCR1 ligands by MH-S cells, levels of
chemotaxis of U-937 towards culture supernatants of
mock-infected cells were only slightly increased as com-
pared to medium control (Figure 3D). This potentially in-
dicates that other mechanisms induced by MVA may be
required for optimal induction of cell migration.Figure 4 MVA, but not VACV WR, induces chemokine production in T
dependent manner. A) Total RNA from MVA or VACV WR infected THP-1
multiprobe ribonuclease protection assay using hCK-5 as probe (upper pan
THP-1 cells (upper panel) and U-937 cells (lower panel) toward control med
MVA or VACV WR at 1 MOI for 16 hours. Where indicated, cells were treate
solvent (all other samples) before running the assay as described in FigureIn a recent study, we showed that complement com-
ponent C5 is required for respiratory recruitment of
neutrophils during MVA infection [21]. Surprisingly,
complement component C3 was not necessary, which
suggests the activation of an unknown proteolytic
process by MVA. Indeed, CCL3 is N-terminally proc-
essed by CD26/dipeptidyl peptidase IV converting it to a
very potent CCR1 ligand [22]. Taken together, in future
studies it would be interesting to investigate whether an
MVA activated protease plays a role in MVA triggered
recruitment of monocytes and neutrophils.
Previously we showed that MVA, but not VACV strain
Elstree, induces chemokine expression including CCR1
acting chemokines in THP-1 cells [12]. Here we confirm
our previous finding using multiprobe ribonuclease pro-
tection assay (RPA) and RT-PCR. Additionally we dem-
onstrated that VACV WR does not induce chemokine
expression in THP-1 cells (Figure 4A) and that superna-
tants from MVA but not VACV WR infected human
monocytic THP-1 cells significantly increase chemotaxis
of both naïve THP-1 cells and U-937 cells as compared
to supernatants from mock infected cells (Figure 4B). As
a side note, treatment of cells with the CCR1 antagonistHP-1 cells and increases chemotaxis of monocytes in a CCR1
cells were isolated 6 hours p.i. and investigated subsequently by
el) and specific RT-PCR as indicated (lower panel). B) Chemotaxis of
ium (CM) and culture supernatants from THP-1 cells infected with
d with 5 nM of CCR1 antagonist J 113863 or the equivalent amount of
3. Data are means ± SD (n = 4). *, P < 0.05. ***, P < 0.001.
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taxis towards supernatants from mock infected cells and
medium controls. This indicates that there was a CCR1
acting ligand present not only in supernatants of mock
infected cells but also in the cell culture medium used.
Indeed, constitutive expression of CCL5 in THP-1 cells
was detected by multiprobe RPA, which may contribute
to that effect (Figure 4A). Additionally, a bovine CCL3 iso-
form capable of inducing THP-1 chemotaxis in a CCR1
dependent manner has been detected in calf serum [23],
and the cell culture medium used here for chemotaxis as-
says regularly contained 0.5% fetal calf serum.
In summary, we demonstrated that MH-S cells can be
used as model system to study MVA infection in alveolar
macrophages but due to the high constitutive production
of C-C motif chemokines only limited conclusions can
be drawn from functional studies where the involvement
of these proteins is relevant. Nevertheless, the results
presented here confirm our recent findings in primary
murine lung fibroblasts and bone marrow derived mac-
rophages showing additionally that MVA, but not VACV
WR, induces chemokine expression in cells of the
monocyte/macrophage lineage that is capable of indu-
cing chemotaxis of neutrophils and monocytes.Additional file
Additional file 1: Verification of RT-PCR for murine CXCL5/GCP-2/
LIX. As indicated, MLE-12 cells were challenged with LPS (1 μg/ml), with
supernatants from MH-S cells (snMH-S) or with supernatants from
LPS-treated MH-S cells (snMH-SLPS) for six hours and subsequently
lysed for total RNA isolation. RNA was converted in cDNA and
amplified using forward primer 5'-catttctgttgctgttcacg-3' and reverse
primer 5'-atacatattccggagacaatgc-3'. Primers were designed using
NCBI Reference Sequence: NM_009141.3; Mus musculus chemokine
(C-X-C motif) ligand 5 (Cxcl5), mRNA. The CXCL5/GCP-2/LIX PCR
product corresponded with the expected size of 617 bp. RT-PCR for
murine GAPDH was performed as described (5). PCR without cDNA
served as negative control. Lambda DNA Hind III/phiX174 DNA Hae
III was used as molecular weight marker (MWM).Competing interests
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